Oakland, CA, United States of America

Stephen Gordon Will

USPTO Granted Patents = 48 


 

Average Co-Inventor Count = 2.3

ph-index = 5

Forward Citations = 310(Granted Patents)


Location History:

  • Walnut Creek, CA (US) (1999)
  • Rotkreuz, CH (2012 - 2013)
  • Cham, CH (2012 - 2016)
  • Oakland, CA (US) (2007 - 2022)

Company Filing History:


Years Active: 1999-2022

where 'Filed Patents' based on already Granted Patents

48 patents (USPTO):

Title: Stephen Gordon Will: Driving Innovation in Biotechnology

Introduction:

Stephen Gordon Will, a prolific inventor based in Oakland, California, has played a significant role in advancing biotechnology through his numerous patents. With a remarkable total of 48 patents to his name, his contributions have pushed the boundaries of plasma separation techniques and improved the stability of nucleotide reagents used in nucleic acid amplification processes. This article delves into Will's latest patents, career highlights, and noteworthy collaborations in the field of biotechnology.

Latest Patents:

One of Stephen Gordon Will's recent patents is the plasma separation card. This multi-layer card comprises a sample receiving member, separating members, absorptive members, and a backing member, designed to facilitate the separation and absorption of plasma from blood samples. This innovative solution enhances the efficiency and accuracy of plasma separation techniques, offering potential benefits in areas such as diagnostics and medical research.

Another notable invention by Will is the photocleavable nucleotide reagents with high stability. These modified nucleoside triphosphates are vital components used in nucleic acid amplification techniques like PCR and RT-PCR. This groundbreaking development ensures greater stability of the reagents during amplification reactions, leading to improved accuracy and reliability in detecting target nucleic acid sequences.

Career Highlights:

Stephen Gordon Will has made significant contributions to Roche Molecular Systems, Inc., a renowned player in molecular diagnostics and biotechnology research. Through his inventive prowess and diligent work, he has amassed a prolific portfolio of patents, totaling an impressive 48. Will's innovations have strengthened Roche Molecular Systems' position as a leader in the field, continually striving to deliver cutting-edge solutions for complex biological challenges.

Collaborations:

In his pursuit of innovation, Stephen Gordon Will has collaborated closely with esteemed colleagues in the biotechnology arena. Notably, Amar Gupta and Veeraiah Bodepudi have worked alongside Will, sharing their expertise and research to further advance biotechnological solutions. Their collaborative efforts have led to remarkable breakthroughs, turning scientific theories into tangible inventions that have the potential to revolutionize the field.

Conclusion:

Stephen Gordon Will's exceptional talent for innovation and his dedication to improving biotechnology have led him to secure 48 patents, solidifying his reputation as a leading innovator in the field. His contributions to plasma separation techniques and the stability of nucleotide reagents have paved the way for advancements in diagnostics, medical research, and genetic analysis. Will's collaborations with esteemed colleagues have further boosted his impact, demonstrating the power of collaboration in shaping the future of biotechnology. As a pioneer in his field, Stephen Gordon Will continues to inspire and push the boundaries of what is possible in the realm of biotechnological innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…